Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intentional Rejection of the Donor Graft Using Recipient Leukocyte Infusion(s) Following Nonmyeloablative Allogeneic Stem Cell Transplant

NCT00909948 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT00909948
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00909948 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intentional Rejection of the Donor Graft Using Recipient Leukocyte Infusion(s) Following Nonmyeloablative Allogeneic Stem Cell Transplant
Lead sponsor
Massachusetts General Hospital
Phase
Phase 1
Overall status
Terminated
Start date
November 30, 2008
Completion date
August 31, 2012
Enrollment
7 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hodgkin disease, multiple myeloma, non hodgkin's lymphoma